Circulating culprit or therapeutic bullseye: lipoprotein(a) in cardiovascular risk assessment and novel therapeutic prospects

Journal of Cardiovascular Aging · Published 2024-01-17 · DOI 10.20517/jca.2023.35

Authors being retrieved — see the publisher record. https://doi.org/10.20517/jca.2023.35

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Role of plasminogen activator inhibitor-1 (PAI-1) in age-related cardiovascular pathophysiology · Journal of Cardiovascular Aging · 2025 · Same journal
• Deep learning-based prognostic prediction in ischemic heart failure using SPECT myocardial perfusion imaging · Journal of Cardiovascular Aging · 2026 · Same journal
• Imidazole propionate: a new direction for atherosclerosis prevention and treatment · Journal of Cardiovascular Aging · 2026 · Same journal
• Mechanisms of cellular senescence-induced vascular aging: evidence of senotherapeutic strategies · Journal of Cardiovascular Aging · 2025 · Same journal
• Reversing an obesogenic diet to control diet partially rescues pro-inflammatory lipid–immune memory in splenocardiac aging · Journal of Cardiovascular Aging · 2025 · Same journal
• The aging heart: exploring the role of Klotho in cardiac health/function · Journal of Cardiovascular Aging · 2024 · Same journal
• The role of senescence in cancer therapy-associated cardiovascular toxicity · Journal of Cardiovascular Aging · 2024 · Same journal
• Long-term prognosis of fulminant myocarditis: a multicenter prospective cohort study in China · Journal of Cardiovascular Aging · 2026 · Same journal
• Acetyltransferase in cardiovascular disease and aging · Journal of Cardiovascular Aging · 2024 · Same journal
• JOSD2 promotes cardiomyocyte apoptosis and exacerbates cardiac injury after myocardial infarction via LKB1-AMPK suppression · Journal of Cardiovascular Aging · 2026 · Same journal